Encompass Health Corporation
General ticker "EHC" information:
- Sector: Health Care
- Industry: Medical - Care Facilities
- Capitalization: $11.1B (TTM average)
Encompass Health Corporation follows the US Stock Market performance with the rate: 36.3%.
Estimated limits based on current volatility of 1.6%: low 98.96$, high 102.24$
Factors to consider:
- Company pays dividends (irregularly): last record date 2026-01-02, amount 0.19$ (Y0.19%)
- Total employees count: 40000 (+5.9%) as of 2024
- Top business risk factors: Cybersecurity threats, Integration challenges, Regulatory and compliance, Third-party risks, Operational and conduct risks
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [85.04$, 117.57$]
- 2025-12-31 to 2026-12-31 estimated range: [89.07$, 123.74$]
Financial Metrics affecting the EHC estimates:
- Negative: with PPE of 21.2 at the end of fiscal year the price was high
- Positive: 7.54 < Operating profit margin, % of 14.26
- Positive: 6.63 < Operating cash flow per share per price, % of 10.71
- Positive: Return on assets ratio (scaled to [-100,100]) of 8.40 > 6.04
- Positive: Interest expense per share per price, % of 1.47 <= 3.31
- Positive: -0.04 < Industry operating cash flow per share per price (median), % of 3.20
- Positive: 19.35 < Shareholder equity ratio, % of 31.63 <= 42.53
Short-term EHC quotes
Long-term EHC plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $4,348.60MM | $4,801.20MM | $5,258.30MM |
| Operating Expenses | $3,718.40MM | $3,076.40MM | $4,508.70MM |
| Operating Income | $630.20MM | $1,724.80MM | $749.60MM |
| Non-Operating Income | $-179.40MM | $-1,117.60MM | $0.00MM |
| Interest Expense | $175.70MM | $143.50MM | $137.40MM |
| Income(Loss) | $450.80MM | $607.20MM | $749.60MM |
| Taxes | $100.10MM | $132.20MM | $150.20MM |
| Other Income(Loss) | $15.20MM | $-12.00MM | $-2.80MM |
| Profit(Loss)* | $271.00MM | $352.00MM | $455.70MM |
| Stockholders Equity | $1,310.30MM | $1,647.50MM | $2,067.00MM |
| Assets | $5,636.50MM | $6,102.40MM | $6,534.70MM |
| Operating Cash Flow | $705.80MM | $850.80MM | $1,002.80MM |
| Capital expenditure | $584.10MM | $583.10MM | $642.50MM |
| Investing Cash Flow | $-627.00MM | $-602.80MM | $-653.30MM |
| Financing Cash Flow | $-145.70MM | $-197.20MM | $-330.60MM |
| Earnings Per Share** | $2.73 | $3.54 | $4.56 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.